Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
January 23, 2023
New computational tools widen horizons for liquid biopsies
Methods allow scientists to use gene regulation patterns to detect cancer subtype in cell-free DNA
Tracking prostate cancer dynamics
Single-cell study brings prostate tumors into focus and highlights potential treatment target: cancer complexity
Structural landscape of DNA and precision medicine, firm handshake
From the Ha lab, Public Health Sciences and Human Biology Divisions
Identification of potential driver mutations in rare prostate cancer subtype
From the Haffner, Lee, and Ha Labs, Prostate Cancer and Biostatistics and Computational Biology Programs, Cancer Consortium.
Award will fund research into new metastatic prostate cancer therapies
Physician-scientist Dr. John Lee and his team will use $750K Kleberg Foundation grant to pursue new treatments, including immunotherapy
Dr. Anat Zimmer receives AAUW fellowship
Fred Hutch computational biologist who relocated from Israel will receive support while investigating cancer genomics
Dr. Ruth Etzioni receives $7.4M NCI grant to assess new cancer diagnostics
Award will provide long-term support to investigate accuracy of multi-cancer liquid biopsies and other new technology
Good and surprising news finds germline mutations are rare in low-risk prostate cancer
From the Nelson Lab, part of the Human Biology and Public Health Sciences Divisions
Access to Prostate Cancer Clinical Trials: A County-Level Analysis
From the Bansal Group, Public Health Sciences Division
Genomic attributes predict cancer treatment responsiveness
From the Nelson Lab, Human Biology & Clinical Research Divisions
Dr. Andrew Hsieh elected member of American Society for Clinical Investigation
Physician-scientist demonstrated central role protein synthesis plays in cancer
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Computational predictions reveal an unexpected synergy for prostate cancer therapy
From the Gujral Lab, Human Biology Division
Highlights of Fred Hutch science in 2021
From COVID-19 to cancer, Hutch scientists pursued new ideas to save lives
Building better lab models of human tumors
Dr. John Lee receives $1.5M NIH New Innovator Award for creative young scientists with high-risk, high-reward projects
Using AI to identify potential COVID-19, cancer therapies
Early findings show current drugs might be repurposed to calm COVID-19’s cytokine storms, treat metastatic prostate cancer
Untranslated, maybe, unappreciated, no more.
From the Hsieh Lab, Human Biology Division
Overlooked stretches of DNA could hide cancer-causing mutations
New cutting-edge technique sheds light on difficult-to-study DNA regions, potential drug targets